Melanotan II: Clinical Mechanism, Dossier & Protocols
Synthetic cyclic heptapeptide analog of alpha-MSH that stimulates melanin production (eumelanin) for deep sunless skin tanning while simultaneously activating central sexual libido pathways.
🔬 Molecular Architecture & Physical Specifications
⚙️ Primary Mechanism of Action
Non-selective melanocortin receptor agonist (MC1R for skin eumelanin production, MC3R/MC4R for appetite suppression and potent central sexual arousal stimulation in the hypothalamus).
💉 Research Dosage & Reconstitution Standard
Requires pharmaceutical-grade 0.9% benzyl alcohol Bacteriostatic Water to inhibit bacterial replication for multi-dose access.
⚠️ Contraindications & Documented Adverse Effects
Strict Contraindications
- Dysplastic nevus syndrome or history of melanoma
- Severe hypertension
Documented Side Effects
- Facial flushing for 30-60 mins after dose
- Transient mild nausea
- Darkening of existing freckles/moles
- Spontaneous erections (priapism risk if overdosed)
📚 Peer-Reviewed References & Authoritative Sources
Citations indexed in PubMed, National Center for Biotechnology Information (NCBI), and ClinicalTrials.gov.
Explore Related Research Modules
Access exact dilution guides, syringe unit calculators, and purity certificates for Melanotan II.